Nerandomilast, an oral phosphodiesterase 4B inhibitor, hit the primary endpoint in a Phase III trial in progressive pulmonary ...
No matter what causes air pollution, it continues to increase throughout the United States, with over 131 million people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback